<style type="text/css">.columns-container__full-width-background.banner__main-hero.background__main-hero {background-image: url("undefined")}@media only screen and (min-width:769px) { .columns-container__full-width-background.banner__main-hero.background__main-hero { background-image: url("undefined")}}</style>
Skip to main content
Dynamic Alerts
Site Logo
Health care professionals website
DPL Global Search
DPL Utility Nav
DPL Main Nav
DPL Global Search
DPL Utility Nav
Breadcrumbs
SubHero Banner
RxNews®
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Starjemza® (ustekinumab-hmny) – New biosimilar approval
May 27, 2025 - Bio-Thera Solutions and Hikma announced the FDA approval of Starjemza (ustekinumab-hmny), biosimilar to Janssen’s Stelara® (ustekinumab).
